JPT2

Chr 16

Jupiter microtubule associated homolog 2

Also known as: C16orf34, HN1L, L11

The protein binds nicotinic acid adenine dinucleotide phosphate (NAADP) and enables NAADP-evoked intracellular calcium release by conferring NAADP sensitivity to two pore channels and activating calcium release from the endoplasmic reticulum through ryanodine receptors. Mutations in JPT2 cause autosomal recessive developmental and epileptic encephalopathy with movement abnormalities, characterized by early-onset seizures, developmental delay, and movement disorders affecting the central nervous system.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 0.86
Clinical SummaryJPT2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.27) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.86LOEUF
pLI 0.233
Z-score 1.82
OE 0.27 (0.110.86)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.45Z-score
OE missense 0.88 (0.751.04)
98 obs / 111.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.27 (0.110.86)
00.351.4
Missense OE0.88 (0.751.04)
00.61.4
Synonymous OE0.83
01.21.6
LoF obs/exp: 2 / 7.3Missense obs/exp: 98 / 111.3Syn Z: 0.85

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

JPT2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →